Theodore R Schroeder Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Theodore R Schroeder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Theodore R Schroeder. Theodore R Schroeder is a Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and a President, CEO in CADENCE PHARMACEUTICALS INC ($CADX) and a Director in HYPERION THERAPEUTICS INC ($HPTX) and a Director in Otonomy, Inc. ($OTIC) and a in Cidara Therapeutics, Inc. ($CDTX) and a Director in Cidara Therapeutics, Inc. ($CDTX) and an Chief Executive Officer in Nabriva Therapeutics plc ($NBRV) and an Chief Executive Officer) in Nabriva Therapeutics plc ($NBRV).
Address: C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO 92130 CA
Companies in which Theodore R Schroeder is an Insider
CADENCE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: President, CEO
Holdings: 0 shares
Latest Transaction: Mar 21 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cidara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Theodore R Schroeder:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
COLLEGIUM PHARMACEUTICAL, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: Director
Holdings: 11,007 shares
Current Value: $169,068
Latest Transaction: May 22 2020
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HYPERION THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: Director
Holdings: 0 shares
Latest Transaction: May 08 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: Chief Executive Officer)
Holdings: 178,203 shares
Current Value: $1,441,662
Latest Transaction: May 10 2021
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OTONOMY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Theodore R Schroeder: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$OTIC Market Capitalization: $442.34M
$OTIC Previous Close: $14.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Theodore R Schroeder
Sentiment: All, CADX, CDTX, COLL, HPTX, NBRV, OTIC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.49 | 225 | 335 | 178,203 | 178.4 K to 178.2 K (-0.13 %) |
| May 04 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.78 | 107 | 190 | 178,428 | 178.5 K to 178.4 K (-0.06 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.90 | 2,695 | 7,816 | 178,985 | 181.7 K to 179 K (-1.48 %) |